2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
Deadline:N/A
Tender information
Grande Lisboa
Grande Lisboa
Type
Contract award
Procedure
Restricted procedure
Ref. number
261Y000106 - B707 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
Estimated value
€457,936.60
Contract type
Framework agreement
Duration
11 months
BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
B707 -BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
Buyer
Unidade Local de Saúde Santa Maria, E.P.E.
Contract award
AMGEN BIOFARMACEUTICA, LDA
AwardedDocuments
Contract award
AMGEN BIOFARMACEUTICA, LDAAwardedBuyer
Unidade Local de Saúde Santa Maria, E.P.E.
Contract awarded
Important dates
24 Jun - Publication date
Unlock Full Access with Mercell Bidding Business Plus
